Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Applying Artificial Intelligence to Identify Subphenotypes of Acute Kidney Injury in Mexican Patients With Severe COVID-19

NCT06471101 is registered in ClinicalTrials.gov with Instituto Nacional de Enfermedades Respiratorias as lead sponsor.

NCT NCT06471101
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06471101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Applying Artificial Intelligence to Identify Subphenotypes of Acute Kidney Injury in Mexican Patients With Severe COVID-19
Lead sponsor
Instituto Nacional de Enfermedades Respiratorias
Phase
Observational
Overall status
Completed
Start date
June 18, 2024
Completion date
June 18, 2024
Enrollment
2,934 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, covid-19